Abstract
Purpose
PREDATORR is the first national study analyzing the prevalence of chronic kidney disease and its prognosis and association with socio-demographic, cardio-metabolic and lifestyle risk factors in the adult Romanian population.
Methods
Chronic kidney disease was defined according to the KDIGO 2012 criteria as an estimated glomerular filtration rate <60 mL/min/1.73 m2 and/or urinary albumin-to-creatinine ratio ≥30 mg/g. The socio-demographic, lifestyle and anamnestic data were collected through interviewer-administered questionnaires. Physical examination and biochemical assays were also performed.
Results
This cross-sectional study conducted between December 2012 and February 2014 in Romania included 2717 adults. The overall age- and sex-adjusted prevalence of chronic kidney disease was 6.74 % (95 %CI 5.60–7.88 %), of which 3.31 % (2.50–4.13 %) had only reduced kidney function (estimated glomerular filtration rate <60 mL/min/1.73 m2), 2.98 % (2.21–3.76 %) had only albuminuria, and 0.45 % (0.14–0.74 %) had both. The prevalence of chronic kidney disease increased with age and was similar in women and in men. Age, hyperuricemia, impaired glucose regulation (diabetes/prediabetes), hypertriglyceridemia and a family history of renal disease were independent risk factors for the presence of chronic kidney disease.
Conclusions
The PREDATORR study showed a high prevalence of chronic kidney disease in the adult Romanian population providing data on its prognosis and association with several cardio-metabolic risk factors.
Similar content being viewed by others
References
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67:2089–2100. doi:10.1111/j.1523-1755.2005.00365.x
Lopez-Giacoman S, Madero M (2015) Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol 4:57–73. doi:10.5527/wjn.v4.i1.57
Levey AS, Coresh J (2012) Chronic kidney disease. Lancet 379:165–180. doi:10.1016/S0140-6736(11)60178-5
Pereira BJ (2000) Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 57:351–365. doi:10.1046/j.1523-1755.2000.00840.x
Obrador GT, Pereira BJ, Kausz AT (2002) Chronic kidney disease in the United States: an underrecognized problem. Semin Nephrol 22:441–448. doi:10.1053/snep.2002.2002.35962
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 1):S1–S266
Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A (2013) Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382:158–169. doi:10.1016/S0140-6736(13)60439-0
Lysaght MJ (2002) Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 13(Suppl 1):S37–S40
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047. doi:10.1001/jama.298.17.2038
Gilg J, Pruthi R, Fogarty D (2015) UK renal registry 17th annual report: chapter 1 UK renal replacement therapy incidence in 2013: National and centre-specific analyses. Nephron 129 (Suppl 1):S1–S29. doi: 10.1159/000370271
Ansell D, Feest T, Byrne C, Ahmad A, Burden R, Burton C, Caskey F, Dudley C, Harper J, Lewis M, Roderick P, Thomas D, Throssel D, Warwick G, Will E, Williams A (2003) National renal review 2002: summary report on adult and paediatric renal services (chapter 3). Available at: https://www.renalreg.org/reports/2003-the-sixth-annual-report/. Accessed 22 July 2015
Meguid El Nahas A, Bello AK (2005) Chronic kidney disease: the global challenge. Lancet 365:331–340. doi:10.1016/S0140-6736(05)17789-7
Cepoi V, Onofriescu M, Segall L, Covic A (2012) The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons. Int Urol Nephrol 44:213–220. doi:10.1007/s11255-011-9923-z
Mota M, Popa SG, Mota E, Mitrea A, Catrinoiu D, Cheta DM, Guja C, Hancu N, Ionescu-Tirgoviste C, Lichiardopol R, Mihai BM, Popa AR, Zetu C, Bala CG, Roman G, Serafinceanu C, Serban V, Timar R, Veresiu IA, Vlad AR (2015) Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study. J Diabetes. doi:10.1111/1753-0407.12297
Brück K, Jager KJ, Dounousi E, Kainz A, Nitsch D, Ärnlöv J, Rothenbacher D, Browne G, Capuano V, Ferraro PM, Ferrieres J, Gambaro G, Guessous I, Hallan S, Kastarinen M, Navis G, Gonzalez AO, Palmieri L, Romundstad S, Spoto B, Stengel B, Tomson C, Tripepi G, Völzke H, Wiȩcek A, Gansevoort R, Schöttker B, Wanner C, Vinhas J, Zoccali C, Van Biesen W, Stel VS, European CKD Burden Consortium (2015) Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrol Dial Transplant 30(Suppl 4):iv6–iv16. doi:10.1093/ndt/gfv131
Kdigo, CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1–150
International Diabetes Federation (IDF). IDF Diabetes Atlas, 6th edn. (2014) International diabetes federation, Brussels, Belgium. 2014 update. Available from: http://www.idf.org/sites/default/files/Atlas-poster-2014_EN.pdf. Accessed 2 Sep 2015
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419. doi:10.1007/BF00280883
Standards of medical care in diabetes—2015 (2015) Diabetes Care 38 (Suppl 1):S1–S94
Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1–12. doi:10.1053/ajkd.2003.50007
Zhou XJ, Rakheja D, Yu X, Saxena R, Vaziri ND, Silva FG (2008) The aging kidney. Kidney Int 74:710–720. doi:10.1038/ki.2008.319
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612. doi:10.7326/0003-4819-150-9-200905050-00006
Singh AK, Kari JA (2013) Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 22:198–203. doi:10.1097/MNH.0b013e32835dda78
Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M (2013) Metabolic syndrome and renal disease. Int J Cardiol 164:141–150. doi:10.1016/j.ijcard.2012.01.013
Segura J, Ruilope L (2011) Hypertension in moderate-to-severe nondiabetic CKD patients. Adv Chronic Kidney Dis 18:23–27
Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang DH, Ritz E (2013) Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant 28:2221–2228. doi:10.1093/ndt/gft029
Wang H, Wei Y, Kong X, Xu D (2013) Effects of urate-lowering therapy in hyperuricemia on slowing the progression of renal function: a meta-analysis. J Ren Nutr 23:389–396. doi:10.1053/j.jrn.2012.08.005
Kanji T, Gandhi M, Clase CM, Yang R (2015) Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol 16:58. doi:10.1186/s12882-015-0047-z
Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW (2014) Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant 29:406–413. doi:10.1093/ndt/gft378
Ryu S, Chang Y, Woo HY, Lee KB, Kim SG, Kim DI, Kim WS, Suh BS, Jeong C, Yoon K (2009) Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 53:59–69. doi:10.1053/j.ajkd.2008.07.027
Acknowledgments
The authors would like to thank the 101 general practitioners who enrolled the participants, filled in the study questionnaires and collected blood and urine samples from the participants. They also acknowledge CEBIS International for study documentation development, feasibility, project management, monitoring, data management, statistical analysis and financial reporting. The authors thank Prof. Dr. Cristian Băicuș for review and validation of the statistical analyses and counseling regarding reporting of the study data. The authors also acknowledge Adriana Rusu and Iudit-Hajnal Filip (XPE Pharma & Science) for writing support. This work was supported by the Romanian Society of Diabetes, Nutrition and Metabolic Diseases, IHS Sofmedica, Abbott, Astra Zeneca, Novo Nordisk, MSD, Servier, Novartis and Worwag Pharma.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest that could have direct or potential influence or impart bias on the work.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Research involving Human Participants and/or Animals
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Eugen Moţa, Simona Georgiana Popa, Maria Moţa and Adina Mitrea have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Moţa, E., Popa, S.G., Moţa, M. et al. Prevalence of chronic kidney disease and its association with cardio-metabolic risk factors in the adult Romanian population: the PREDATORR study. Int Urol Nephrol 47, 1831–1838 (2015). https://doi.org/10.1007/s11255-015-1109-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-015-1109-7